During the past decade, Ospedale Monaldi conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 9 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Monaldi" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Azienda Ospedaliera Cardinale G. Panico" with 4 trials sponsored, "Monaldi Hospital" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "European Institute of Oncology" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Monaldi" #1 collaborator was "Eustrategy" with 1 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Monaldi" are "Heart Failure" (5 trials), "Atrial Fibrillation" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Heart Failure With Reduced Ejection Fraction" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Ospedale Monaldi" in a lesser frequency.

Most popular intervention types in "Ospedale Monaldi" are "Drug" (19 trials), "Device" (13 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "cisplatin" (3 trials), "LEE011" (2 trials), "LGX818" (2 trials) and "MEK162" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Monaldi" are 44 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Monaldi". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Ospedale Monaldi, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Monaldi, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".